Somatostatin Analogs Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 - Opportunities in the Acromegaly and Neuroendocrine Tumor Markets Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "Somatostatin Analogs Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...

Global Somatostatin Analogs Market to Reach $8.67 Billion by 2028 - Forecast Shows Rapid Growth in Asia-Pacific and Innovation Trends Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Somatostatin Analogs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global market for somatostatin...

Somatostatin Analogs Market revenue to reach USD 10 Billion by 2035, says Research Nester New York, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The global somatostatin analogs market size is slated to expand at ~6% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 10...

Somatostatin Analogs Market revenue to reach USD 10 Billion by 2035, says Research Nester New York, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The global somatostatin analogs market size is predicted to expand at ~ 6% CAGR between 2023 and 2035. The market is projected to garner a revenue of USD...

Global Somatostatin Analogs Market Intelligence Report to 2027 - Featuring CVS Health, Ipsen Pharma and Pfizer Among Others Dublin, July 25, 2022 (GLOBE NEWSWIRE) -- The "Somatostatin Analogs Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global...